Melatonin with magnesium
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that melatonin and magnesium co-supplementation can improve sleep quality, reduce inflammation and metabolic issues, provide neuroprotection, and have potential benefits for conditions like PCOS, diabetes, and hypoxic-ischemic encephalopathy.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
The Synergistic Effects of Melatonin and Magnesium Supplementation
Introduction to Melatonin and Magnesium
Melatonin and magnesium are two compounds known for their wide range of health benefits, including anti-inflammatory, antioxidant, and neuroprotective effects. Recent research has explored their combined use in various health conditions, revealing promising results.
Melatonin and Magnesium in Polycystic Ovary Syndrome (PCOS)
Anti-Inflammatory and Antioxidant Benefits
In women with PCOS, a study found that co-supplementation of melatonin and magnesium for 8 weeks significantly reduced serum levels of tumor necrosis factor-alpha (TNF-α), an inflammatory marker, and increased total antioxidant capacity (TAC) levels compared to other treatment groups. This suggests that the combination of these supplements can effectively reduce inflammation and oxidative stress in PCOS patients.
Metabolic and Hormonal Improvements
Another study on PCOS women demonstrated that melatonin and magnesium co-supplementation significantly improved metabolic profiles. This included reductions in serum insulin levels, homeostasis model assessment of insulin resistance (HOMA-IR), cholesterol, low-density lipoprotein cholesterol (LDL-C), and testosterone levels. Additionally, there was an increase in high-density lipoprotein cholesterol (HDL-C) levels. These findings indicate that the combination of melatonin and magnesium can positively influence both metabolic and hormonal parameters in PCOS.
Neuroprotective Effects in Neonatal Hypoxic-Ischemic Encephalopathy
Reduction in Brain Injury Markers
In a neonatal hypoxic-ischemic rat model, the combination of magnesium sulfate and melatonin significantly reduced brain infarct volume and neuronal apoptosis compared to control groups. Similarly, a clinical trial on infants with hypoxic-ischemic encephalopathy (HIE) showed that the addition of magnesium sulfate to melatonin therapy resulted in a greater reduction in the brain injury marker S100-B compared to melatonin alone. These studies highlight the potential neuroprotective benefits of combining melatonin and magnesium in neonatal brain injuries.
Benefits in Diabetes Management
Insulin Secretion and Pancreatic Health
Research on streptozotocin-induced diabetic rats revealed that low-dose co-administration of melatonin and magnesium improved pancreatic islet histoarchitecture and augmented insulin release. This suggests that the combination can help regenerate pancreatic tissue and enhance insulin secretion, offering a potential therapeutic approach for diabetes management.
Neuroprotection in Diabetic Encephalopathy
Further studies on diabetic rats indicated that melatonin and magnesium co-administration increased neuroprotection in the hippocampus by upregulating BCL-2 protein and downregulating Bax protein, which are involved in cell survival and apoptosis, respectively . This neuroprotective effect could be beneficial in managing diabetic encephalopathy and its complications.
Sleep Quality and Insomnia Treatment
Improved Sleep Parameters
A study on the treatment of insomnia found that a combination of magnesium, melatonin, and vitamin B complex significantly improved sleep quality over three months. The Athens Insomnia Scale (AIS) scores were notably lower in the treatment group compared to the control group, indicating reduced insomnia severity. This suggests that melatonin and magnesium, along with other supplements, can effectively enhance sleep quality.
Conclusion
The combination of melatonin and magnesium has shown significant benefits across various health conditions, including PCOS, neonatal brain injuries, diabetes, and insomnia. These supplements work synergistically to reduce inflammation, improve metabolic and hormonal profiles, protect against neuronal damage, and enhance sleep quality. Further research and clinical trials could solidify their role in therapeutic protocols for these conditions.
Sources and full results
Most relevant research papers on this topic
